Reference Hub: FDA warning Elmiron Pigmentary Maculopathy

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Recommended deep-dive

FDA warning Elmiron Pigmentary Maculopathy Resource Guide

A focused review of background, context, and source material on this subject.

Mayo Clinic — Diseases & Conditions

Reference: Mayo Clinic — Diseases & Conditions

Authoritative source for clinical, regulatory, and public-health background reading.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.